A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer

Published:2014-09-01 Issue:27 Volume:34 Page:3547-3555
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Kasinski A L,Kelnar K,Stahlhut C,Orellana E,Zhao J,Shimer E,Dysart S,Chen X,Bader A G,Slack F J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2014282.pdf

Reference34 articles.

1. National Lung Screening Trial Research Team, National Lung Screening Trial Research Team Aberle DR, National Lung Screening Trial Research Team Berg CD, National Lung Screening Trial Research Team Black WC, National Lung Screening Trial Research Team Church TR, National Lung Screening Trial Research Team Fagerstrom RM et al. The National Lung Screening Trial: overview and study design. Radiology 2011; 258: 243–253.

2. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189–198.

3. Lin P-Y, Yu S-L, Yang P-C . MicroRNA in lung cancer. Br J Cancer 2010; 103: 1144–1148.

4. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635–647.

5. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753–3756.

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A signature of circulating miRNAs predicts the prognosis and therapeutic outcome of taxane/platinum regimen in advanced ovarian carcinoma patients;Clinical and Translational Oncology;2024-03-12

2. Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions;Cancer Cell International;2024-01-10

3. MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential;Cancers;2023-09-26

4. A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy;Oncogene;2023-09-05

5. MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis;Pharmacological Research;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3